Terms: = Thyroid cancer AND PTEN, MMAC1, 5728, MGC11227, PTEN1, MHAM, P60484, BZS, ENSG00000171862 AND Prognosis
48 results:
1. thyroid dysfunction caused by exposure to environmental endocrine disruptors and the underlying mechanism: A review.
He J; Xu J; Zheng M; Pan K; Yang L; Ma L; Wang C; Yu J
Chem Biol Interact; 2024 Mar; 391():110909. PubMed ID: 38340975
[TBL] [Abstract] [Full Text] [Related]
2. SHMT2 promotes papillary thyroid cancer metastasis through epigenetic activation of AKT signaling.
Sun M; Zhao M; Li R; Zhang Y; Shi X; Ding C; Ma C; Lu J; Yue X
Cell Death Dis; 2024 Jan; 15(1):87. PubMed ID: 38272883
[TBL] [Abstract] [Full Text] [Related]
3. Anaplastic thyroid cancer:Improved understanding of what remains a deadly disease.
Cleere EF; Prunty S; O'Neill JP
Surgeon; 2024 Feb; 22(1):e48-e53. PubMed ID: 37866980
[TBL] [Abstract] [Full Text] [Related]
4. TRIP6 disrupts tight junctions to promote metastasis and drug resistance and is a therapeutic target in colorectal cancer.
Gou H; Wong CC; Chen H; Shang H; Su H; Zhai J; Liu W; Liu W; Sun D; Wang X; Yu J
Cancer Lett; 2023 Dec; 578():216438. PubMed ID: 37827326
[TBL] [Abstract] [Full Text] [Related]
5. Analysis of clinicopathological characteristics and prognostic factors of early-stage human epidermal growth factor receptor 2 (HER2)-low breast cancer: Compared with HER2-0 breast cancer.
Wu Q; Yang F; Liu Y; Zhang H; Zhang S; Xin L; Xu L
Cancer Med; 2023 Oct; 12(19):19560-19575. PubMed ID: 37772432
[TBL] [Abstract] [Full Text] [Related]
6. p53 and pten expression evaluation with molecular evident recent criteria in laryngeal carcinoma.
Tan A; Eskiizmir G; Kamiloglu U; Sarioglu S
Medicine (Baltimore); 2023 May; 102(19):e33676. PubMed ID: 37171328
[TBL] [Abstract] [Full Text] [Related]
7. The impact of PIK3CA mutations and pten expression on the effect of neoadjuvant therapy for postmenopausal luminal breast cancer patients.
Hayama S; Nakamura R; Ishige T; Sangai T; Sakakibara M; Fujimoto H; Ishigami E; Masuda T; Nakagawa A; Teranaka R; Ota S; Itoga S; Yamamoto N; Nagashima T; Otsuka M
BMC Cancer; 2023 Apr; 23(1):384. PubMed ID: 37106324
[TBL] [Abstract] [Full Text] [Related]
8. Targeting the E3 ligase NEDD4 as a novel therapeutic strategy for IGF1 signal pathway-driven gastric cancer.
Wang K; Yu Y; Wang W; Jiang Y; Li Y; Jiang X; Qiao Y; Chen L; Zhao X; Liu J; Yang A; Li J; Zhang R
Oncogene; 2023 Mar; 42(14):1072-1087. PubMed ID: 36774408
[TBL] [Abstract] [Full Text] [Related]
9. Complete pathological response following chemotherapy and radiotherapy in two cases of advanced anaplastic thyroid carcinoma.
Chevalier B; Karleskind O; Jannin A; Farchi O; Vermaut C; Escande A; Baillet C; Espiard S; Vantyghem MC; Carnaille B; Leteurtre E; Do Cao C
Eur Thyroid J; 2023 Feb; 12(1):. PubMed ID: 36377723
[TBL] [Abstract] [Full Text] [Related]
10. Significance of oncocytic features in poorly differentiated thyroid carcinoma - a bi-institutional experience.
Xu B; Lubin DJ; Dogan S; Ghossein RA; Viswanathan K
Virchows Arch; 2023 Mar; 482(3):479-491. PubMed ID: 36346459
[TBL] [Abstract] [Full Text] [Related]
11. MiR-200c promotes papillary thyroid cancer cell proliferation, migration, and invasion by downregulating pten.
Guo K; Wang J; Shu L; Zhou G
Tissue Cell; 2021 Dec; 73():101647. PubMed ID: 34543800
[TBL] [Abstract] [Full Text] [Related]
12. Primary high-grade non-anaplastic thyroid carcinoma: a retrospective study of 364 cases.
Xu B; David J; Dogan S; Landa I; Katabi N; Saliba M; Khimraj A; Sherman EJ; Tuttle RM; Tallini G; Ganly I; Fagin JA; Ghossein RA
Histopathology; 2022 Jan; 80(2):322-337. PubMed ID: 34449926
[TBL] [Abstract] [Full Text] [Related]
13. Whole-genome Sequencing of Follicular thyroid Carcinomas Reveal Recurrent Mutations in MicroRNA Processing Subunit DGCR8.
Paulsson JO; Rafati N; DiLorenzo S; Chen Y; Haglund F; Zedenius J; Juhlin CC
J Clin Endocrinol Metab; 2021 Oct; 106(11):3265-3282. PubMed ID: 34171097
[TBL] [Abstract] [Full Text] [Related]
14. Notch3 inhibits cell proliferation and tumorigenesis and predicts better prognosis in breast cancer through transactivating pten.
Zhang YQ; Liang YK; Wu Y; Chen M; Chen WL; Li RH; Zeng YZ; Huang WH; Wu JD; Zeng D; Gao WL; Chen CF; Lin HY; Yang RQ; Zhu JW; Liu WL; Bai JW; Wei M; Wei XL; Zhang GJ
Cell Death Dis; 2021 May; 12(6):502. PubMed ID: 34006834
[TBL] [Abstract] [Full Text] [Related]
15. EGR1/2 Inhibits Papillary thyroid Carcinoma Cell Growth by Suppressing the Expression of pten and BAX.
Guo H; Zhang L
Biochem Genet; 2021 Dec; 59(6):1544-1557. PubMed ID: 33973090
[TBL] [Abstract] [Full Text] [Related]
16. The emerging roles of dual-specificity phosphatases and their specific characteristics in human cancer.
Gao PP; Qi XW; Sun N; Sun YY; Zhang Y; Tan XN; Ding J; Han F; Zhang Y
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188562. PubMed ID: 33964330
[TBL] [Abstract] [Full Text] [Related]
17. BGL3 inhibits papillary thyroid carcinoma progression via regulating pten stability.
Zhao M; Yang F; Sang C; Yan C; Wang Z
J Endocrinol Invest; 2021 Oct; 44(10):2165-2174. PubMed ID: 33543443
[TBL] [Abstract] [Full Text] [Related]
18. Neddylation of pten regulates its nuclear import and promotes tumor development.
Xie P; Peng Z; Chen Y; Li H; Du M; Tan Y; Zhang X; Lu Z; Cui CP; Liu CH; He F; Zhang L
Cell Res; 2021 Mar; 31(3):291-311. PubMed ID: 33299139
[TBL] [Abstract] [Full Text] [Related]
19. Circular RNA Circ_0000442 acts as a sponge of MiR-148b-3p to suppress breast cancer via pten/PI3K/Akt signaling pathway.
Zhang XY; Mao L
Gene; 2021 Jan; 766():145113. PubMed ID: 32891771
[TBL] [Abstract] [Full Text] [Related]
20. Dissecting Anaplastic thyroid Carcinoma: A Comprehensive Clinical, Histologic, Immunophenotypic, and Molecular Study of 360 Cases.
Xu B; Fuchs T; Dogan S; Landa I; Katabi N; Fagin JA; Tuttle RM; Sherman E; Gill AJ; Ghossein R
Thyroid; 2020 Oct; 30(10):1505-1517. PubMed ID: 32284020
[No Abstract] [Full Text] [Related]
[Next]